SCHEMBL5899732

SCHEMBL5899732

NCC1(C(=O)O)CC1(CCOCc1ccccc1)CCOCc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.38
HTT P42858 1/20 0.38
TSHR P16473 1/20 0.38
EPHX2 P34913 1/20 0.38
TEAD3 Q99594 1/20 0.36
SLC1A1 P43005 3/20 0.36
SLC1A3 P43003 2/20 0.36
SLC1A2 P43004 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
GAA P10253 1/20 0.36
SPHK1 Q9NYA1 2/20 0.35
LMNA P02545 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899733 0.92 EPHX2 (0.41) ALDH1A1SMN1; SMN2HTTTSHREPHX2
SCHEMBL5899565 0.86 TSHR (0.40) ALDH1A1SMN1; SMN2TSHRSLC1A1SLC1A3
SCHEMBL20295088 0.73 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2HTTTSHREPHX2
SCHEMBL25237906 0.71 TSHR (0.47) ALDH1A1TSHREPHX2KDM4EPOLB
SCHEMBL4161505 0.71 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2HTTTSHREPHX2
SCHEMBL6651296 0.71 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2HTTTSHREPHX2
SCHEMBL3369328 0.71 MAOA (0.52) ALDH1A1TSHRKDM4EPOLB
SCHEMBL20703744 0.70 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2HTTTSHREPHX2
SCHEMBL16761714 0.70 EPHX2 (0.45) ALDH1A1SMN1; SMN2HTTTSHREPHX2
SCHEMBL5899630 0.69 EPHX2 (0.42) SMN1; SMN2HTTTSHREPHX2TEAD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030267-B2 Cycloproply β-amino acid derivatives WARNER-LAMBERT COMPANY, LLC (US) 2006-04-18 US disclosed
US-20040147608-A1 Cyclopropyl beta-amino acid derivatives SCHWARZ JACOB BRADLEY (US) 2004-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147608-A1 Cyclopropyl beta-amino acid derivatives CACNA1S, CACNA1D, CACNA1B ALDH1A1 1295/4885SMN1; SMN2 627/4885HTT 2294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.